SANGAMO THERAPEUTICS, INC (SGMO) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Sangamo Therapeutics, Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Sangamo Therapeutics, Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.46 B, a 29.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.46 B -$328 M -29.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$1.41 B -$258 M -22.4% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$1.35 B -$250 M -22.8% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$1.24 B -$199 M -19% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$1.13 B -$127 M -12.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$1.15 B -$192 M -20.1% Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$1.1 B -$178 M -19.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$1.04 B -$172 M -19.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$1 B -$176 M -21.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$956 M -$178 M -22.9% Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$919 M -$181 M -24.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$871 M -$135 M -18.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$824 M -$124 M -17.7% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 -$778 M -$121 M -18.4% Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$737 M -$75.8 M -11.5% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 -$736 M -$102 M -16% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$700 M -$95.9 M -15.9% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 -$657 M -$94.3 M -16.8% Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$662 M -$118 M -21.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$634 M -$103 M -19.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$604 M -$89.4 M -17.4% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$563 M -$67.2 M -13.6% Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$544 M -$61.6 M -12.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$531 M -$61.2 M -13% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$515 M -$57 M -12.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$495 M -$54.6 M -12.4% Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$482 M -$51.1 M -11.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 -$470 M -$57.7 M -14% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$458 M -$71.8 M -18.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$441 M -$71.7 M -19.4% Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$431 M -$76 M -21.4% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 -$412 M -$66.3 M -19.2% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 -$386 M -$51.9 M -15.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 -$369 M -$40.7 M -12.4% Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$355 M -$31 M -9.56% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 -$346 M -$29.3 M -9.26% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 -$334 M -$24.2 M -7.8% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 -$329 M -$26.4 M -8.74% Dec 31, 2014 10-K 2016-02-18
Q3 2014 -$324 M -$30.2 M -10.3% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 -$317 M -$28.8 M -10% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 -$310 M -$27.3 M -9.67% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 -$302 M -$26.6 M -9.66% Dec 31, 2013 10-K 2015-02-25
Q3 2013 -$294 M -$22 M -8.07% Sep 30, 2013 10-Q 2013-11-04
Q2 2013 -$288 M -$21.6 M -8.11% Jun 30, 2013 10-Q 2013-08-02
Q1 2013 -$282 M -$21.9 M -8.4% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 -$276 M -$22.3 M -8.79% Dec 31, 2012 10-K 2014-02-24
Q3 2012 -$272 M -$25.1 M -10.2% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 -$266 M -$28.9 M -12.2% Jun 30, 2012 10-Q 2012-08-03
Q1 2012 -$261 M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 -$253 M -$35.8 M -16.4% Dec 31, 2011 10-K 2013-02-26
Q3 2011 -$247 M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 -$237 M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 -$217 M Dec 31, 2010 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.